FDA Pushes For $225M In User Fees To Finish FSMA
A U.S. Food and Drug Administration official on Wednesday told Congress to back proposed user fees despite industry objections, saying the agency needs the projected $225 million the fees would provide...To view the full article, register now.
Already a subscriber? Click here to view full article